OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 3.675
-0.145 (-3.80%)
Sep 4, 2026, 11:57 AM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 62.58 million as of September 3, 2026. Its market cap has decreased by -23.16% in one year.
Market Cap
62.58M
Enterprise Value
69.33M
Revenue
5.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.68
ChartMarket Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 62.58M, a decrease of -29.70%. That is a compound annual growth rate of -6.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 62.58M | -26.80% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 132.28M |
| Biovica International AB | 127.57M |
| Nanologica AB | 120.33M |
| Annexin Pharmaceuticals AB | 93.89M |
| Spago Nanomedical AB | 88.22M |
| Ascelia Pharma AB | 82.12M |
| Modus Therapeutics Holding AB | 71.97M |
| Pila Pharma AB | 63.73M |